New York Islanders Partner with Vanda Pharmaceuticals
The New York Islanders have officially announced a landmark multi-year agreement with Vanda Pharmaceuticals, a leading biopharmaceutical company. This partnership marks a significant moment in the NHL as Vanda becomes the league’s first-ever pharmaceutical jersey patch partner. Beginning October 9, 2025, fans will see the Vanda logo proudly displayed on both the home and away jerseys of the Islanders.
This collaboration will kick off during the Islanders' matchup against the Pittsburgh Penguins, with the excitement continuing into their home opener on October 11 against the Washington Capitals at the UBS Arena. Not only will the Vanda branding be visible on the jerseys, but it will also be featured prominently across signage at UBS Arena and on various social media platforms associated with the team throughout the season.
In addition to the visual integration, the partnership emphasizes fan engagement through various initiatives. This includes an annual sweepstakes, team-focused content collaborations, and community programs that will culminate in a ceremonial puck drop, celebrating the partnership at UBS Arena.
"Vanda is a company dedicated to innovation and community, values that resonate deeply with the Islanders and our fan base," commented Dan Griffis, President of Global Partnerships at Oak View Group, who manages the Islanders' corporate partnerships. "We believe this unique collaboration will not only provide significant visibility for Vanda but also create new, meaningful experiences for our fans both locally and globally."
To further engage the Islands' community, the Islanders and Vanda will kick off a fan-oriented sweepstakes, providing supporters with the chance to win jerseys embellished with the new Vanda patch, introducing fans to a new season filled with promise and anticipation.
Mihael H. Polymeropoulos, MD, CEO and President of Vanda Pharmaceuticals, expressed pride in this partnership, stating, "We are thrilled to be integrating our brand with such a historic organization as the New York Islanders, becoming the first pharmaceutical jersey patch partner in the NHL. Vanda's commitment to health, happiness, and excellence aligns closely with the ethos of the Islanders organization, and we are excited about the season ahead."
Adam Cross, Senior Vice President of Corporate Partnerships for the Islanders, shared his enthusiasm for this new relationship, emphasizing, "This is a groundbreaking deal for both our organization and the NHL. We are excited to welcome Vanda Pharmaceuticals to the Islanders' family as our exclusive jersey patch partner, and we look forward to a successful collaboration that will not only elevate both of our brands but will also deepen our engagement with the league's most passionate fan base."
About Vanda Pharmaceuticals
Vanda Pharmaceuticals is recognized worldwide for its dedication to developing innovative therapies that address significant unmet medical needs, ultimately improving the lives of patients. More information about Vanda Pharmaceuticals Inc. can be found on their website at
www.vandapharma.com and via their social media on X at @vandapharma.
About the New York Islanders
The New York Islanders Hockey Club boasts a rich legacy, including four Stanley Cup Championships and an impressive nineteen consecutive playoff series victories. Competing in the NHL's Eastern Conference, the Islanders feature eight players, two general managers, and one coach enshrined in the Hockey Hall of Fame. The Islanders Children's Foundation has made a difference in countless young lives globally by raising funds through the efforts of players, management, staff, and their dedicated fan base. The state-of-the-art UBS Arena not only serves as the team's home but offers world-class hospitality and an intimate atmosphere for fans. For exclusive team merchandise, fans can visit Isles Lab both in the arena and online at IslesLab.com.